Cargando…
Infliximab for the treatment of refractory immune-related hepatitis secondary to checkpoint inhibitors: A case report
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7001532/ https://www.ncbi.nlm.nih.gov/pubmed/32039353 http://dx.doi.org/10.1016/j.jhepr.2019.02.001 |
Sumario: |
---|